Viyash Scientific Limited (BOM:512529)

India flag India · Delayed Price · Currency is INR
201.30
+7.20 (3.71%)
At close: Jan 22, 2026
13.44%
Market Cap87.71B
Revenue (ttm)16.58B
Net Income (ttm)418.08M
Shares Out435.72M
EPS (ttm)1.62
PE Ratio124.03
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,481
Average Volume34,281
Open195.00
Previous Close194.10
Day's Range195.00 - 201.90
52-Week Range111.00 - 260.30
Beta0.96
RSI52.89
Earnings DateFeb 5, 2026

About Viyash Scientific

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is h... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 1,244
Stock Exchange Bombay Stock Exchange
Ticker Symbol 512529
Full Company Profile

Financial Performance

Financial Statements

News

Sequent Scientific Ltd (BOM:512529) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...

Sequent Scientific Ltd (BOM:512529) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Merger Approval

2 months ago - GuruFocus

Q2 2026 SeQuent Scientific Ltd Earnings Call Transcript

Q2 2026 SeQuent Scientific Ltd Earnings Call Transcript

2 months ago - GuruFocus

SeQuent Scientific shares jump over 10% as NCLT approves merger with Viyash Lifesciences

Shares of SeQuent Scientific Ltd. surged more than 10% after the company announced that the National Company Law Tribunal (NCLT)...

2 months ago - Business Upturn

Sequent Scientific Q4 Results: Revenue up 11% YoY to Rs 401 crore

Sequent Scientific Limited reported a strong operational performance for the quarter ended March 31, 2025 (Q4 FY25), marking a turnaround from a loss-making position in the same period last year. The ...

8 months ago - Business Upturn

Sequent Scientific Ltd (BOM:512529) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ...

Sequent Scientific Ltd (BOM:512529) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion

1 year ago - GuruFocus

Sequent Scientific Q3 FY25 results: Revenue up 18.7% YoY to Rs 390.8 crore, Net profit declines 58.5% YoY

Sequent Scientific reported a net profit of Rs 3.4 crore for the quarter ending December 31, 2024, marking a significant 58.5% drop compared to Rs 8.2 crore in Q3 FY24. Despite this, the company witne...

1 year ago - Business Upturn

India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc.

Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 06, 2025 (GLOBE NEWSWIRE) -- The India animal healthcare market is experiencing significant growth, driven by a rising livestock popula...

1 year ago - Benzinga

SeQuent Scientific consolidates ownership of subsidiaries in Sweden and Italy

N-VET AB and Alivira Italia SRL specialize in trading animal healthcare products, reinforcing SeQuent’s commitment to advancing its pharmaceuticals portfolio.

1 year ago - Business Upturn

Q2 2025 SeQuent Scientific Ltd Earnings Call Transcript

Q2 2025 SeQuent Scientific Ltd Earnings Call Transcript

1 year ago - GuruFocus

Sequent Scientific and Viyash Life Sciences announce merger to create animal pharma leader

Sequent Scientific has announced a merger with Viyash Life Sciences to form a platform with strong leadership in animal pharmaceuticals. This new combined entity aims to have integrated capabilities a...

1 year ago - Business Upturn

Sequent Scientific shares surge nearly 9% following merger with Viyash Life Sciences

Sequent Scientific shares jumped nearly 9% on September 26, 2024, after the company announced a merger with Viyash Life Sciences. The merger will create a platform with leadership in animal pharmaceut...

1 year ago - Business Upturn

SeQuent Scientific hits 52-week high, surges nearly 9% in 20 minutes

Shares of SeQuent Scientific soared by nearly 9% within just 20 minutes during trading today. As of 2:50 PM, the stock price spiked from ₹177.52 to ₹193, marking an 8.72% increase in a short span. By ...

1 year ago - Business Upturn

SeQuent Scientific shares surge 7% after WHO pre-qualification approval for Albendazole API

Shares of SeQuent Scientific Ltd rose by 7% following the company’s announcement that it has received prequalification approval from the World Health Organization (WHO) for its Albendazole Active Phar...

1 year ago - Business Upturn

Sequent Scientific Ltd (BOM:512529) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue ...

Sequent Scientific Ltd (BOM:512529) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth and Record EBITDA

1 year ago - GuruFocus

Q1 2025 SeQuent Scientific Ltd Earnings Call Transcript

Q1 2025 SeQuent Scientific Ltd Earnings Call Transcript

1 year ago - GuruFocus